Ginkgo Forte GP - References

I Product Info I Ingredients
I Recommended Use
I Clinical Trials
I Research Brief
I References

ginkgol

 

 

 

Low USA domestic & international

shipping

Indication: coronary, cerebral and peripheral circulation impairment; decreased vessel elasticity and increased vascular permeability; stress, intense mental activity, memory impairment; diminished eyesight.

Actions: improves cerebral and peripheral blood circulation, strengthens the cardiovascular system, decreases vascular permeability, improves blood vessel wall elasticity, reduces the tendency of blood to clot in blood vessels, supports cognitive function, improves memory and concentration, improves eye health, potent antioxidant.

Ingredients (per 1 capsule): 

Ginkgo Biloba leaf extract (50:1) (Standardized to 24% Ginkgo flavone glycosides – 19.2 mg and 6% terpene lactones – 4.8 mg) (equivalent to 4000 mg of crude herb) - 80.0 mg, Gotu Kola (Centella asiatica) leaf extract (12:1) (10% asiaticosides – 15 mg) (equivalent to 1800 mg of crude herb) – 150 mg.

 

Ginkgo Forte GP - References:

1. Drieu K. Preparation and definition of Ginkgo biloba extract. In: Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic. Fünfgeld EW, ed. Berlin: Springer-Verlag, 32-6.
2. Mix JA, Crews WD. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. J Altern Complement Med 2000;6:219-29.
3. Clostre F. From the body to the cell membranes: the different levels of pharmacological action of Ginkgo biloba extract. In: Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic.Fünfgeld EW, ed. Berlin: Springer-Verlag, 1988, 180-98.
4. Lebuisson DA, Leroy L, Rigal G. Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind, drug versus placebo study. Presse Med 1986;15:1556-8 [in French].
5. Kartnig T. Clinical applications of Centella asiatica (L) Urb. In Herbs, Spices, and Medicinal Plants: Recent Advances in Botany, Horticulture, and Pharmacology, vol. 3., Craker LE, Simon JE (eds). Phoenix, AZ: Oryx Press, 1986, 145-73.
6. Kleijnen, P Knipschild. Gingko biloba for cerebral insufficiency. British Journal of Clinical Pharmacology 1992 34: 352-8.
7. Grässel E. Effect of Ginkgo-biloba extract on mental performance. Double-blind study using computerized measurement conditions in patients with cerebral insufficiency. Fortschr Med. 1992 Feb 20;110(5):73-6
8. Schubert et al. Depressive episode primarily unresponsive to therapy in elderly patients: efficacy of ginkgo biloba extract (EGB 761) in combination with antidepressants. Geriatr Forsch 1993;3:45-53.
9. Sikora R, et al. Ginkgo biloba extract in the therapy of erectile dysfunction. J Urol 1989;141:188A.
10. Con  Stough, Jodi  Clarke, Jenny  Lloyd, Pradeep J.  Nathan. Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. The International Journal of Neuropsychopharmacology (2001), 4: 131-134 Cambridge University Press
11. Abdel-Kader R, Hauptmann S, Keil U, Scherping I, Leuner K, Eckert A, Müller WE. Pharmacol Res. Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). 2007 Dec;56(6):493-502. Epub 2007 Sep 15.
12. Lin H, Wang H, Chen D, Gu Y. Microsurgery. A dose-effect relationship of Ginkgo biloba extract to nerve regeneration in a rat model. 2007;27(8):673-7
13. Siegel G, Schäfer P, Winkler K, Malmsten M. Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis. Wien Med Wochenschr. 2007;157(13-14):288-94
14. Sakakibara H, Ishida K, Grundmann O, Nakajima J, Seo S, Butterweck V, Minami Y, Saito S, Kawai Y, Nakaya Y, Terao J. Biol Pharm Bull. Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models. 2006 Aug;29(8):1767-70
15. Hibatallah J, Carduner C, Poelman MC. In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. J Pharm Pharmacol. 1999 Dec;51(12):1435-40
16. Pointel JP, Boccalon H, Cloarec M, et al. Titrated extract of Centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs. Angiology 1986;37:420-1
17. Shukla A, Rasik AM, Dhawan BN. Asiaticoside-induced elevation of antioxidant levels in healing wounds. Phytother Res. 1999 Feb;13(1):50-4.
18. Morisset R, Cote NG, Panisset JC, et al. Evaluation of the healing activity of hydrocotyle tincture in the treatment of wounds. Phytother Res 1987;1:117-21.
19. Jayashree G, Kurup Muraleedhara G, Sudarslal S, Jacob VB. Anti-oxidant activity of Centella asiatica on lymphoma-bearing mice. Fitoterapia. 2003 Jul;74(5):431-4.
20. Bradwejn J, Zhou Y, Koszycki D, et al. A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol. 2000;20:680–684.